相关实验视频
Updated: Jul 6, 2025

09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
15.4K
由于新型MYBPC1变异而产生的先天性震和肌肉病变
Heather Leduc-Pessah1, Ian C Smith2, Kristin D Kernohan3
1Department of Pediatrics, Neurology, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
Journal of the neurological sciences
|January 7, 2024
概括
带着震的先天性肌肉病 (MYOTREM) 与MYBPC1基因变异有关. 这项研究确定了一种新的MYBPC1变种,即使在睡眠期间也会引起持续的震,并揭示了肌肉缩和脂肪透.
科学领域:
- 遗传学 遗传学是一种遗传学.
- 神经肌肉疾病 神经肌肉疾病
- 分子生物学分子生物学
背景情况:
- 带着震的先天性肌肉病 (MYOTREM) 是一种罕见的遗传疾病.
- 它的特点是从婴儿时期起轻微的肌肉虚弱和.
- MYOTREM与MYBPC1基因中的致病变体有关,该基因编码的是缓慢的肌结合蛋白C.
研究的目的:
- 描述一个患有 MYBPC1 新型变异导致 MYOTREM 的家庭.
- 描述这种新型变种的临床和成像特征.
- 为了研究MYOTREM的遗传基础.
主要方法:
- 对受影响的家庭成员进行遗传分析.
- 对患者的临床评估.
- 肌肉磁共振成像 (MRI). 肌肉磁共振成像.
主要成果:
- 在三代中识别了一种新型MYBPC1变种 (c.656 T > C,p.Leu219Pro).
- 受影响的个体表现出持续的震,包括在睡眠期间.
- 肌肉MRI显示肌肉缩和脂肪透.
结论:
- 新型MYBPC1变种是致病的,并导致MYOTREM.
- 持续的震,即使在睡眠中,也是一个关键特征.
- 肌肉缩和脂肪透是MYOTREM的重要发现.
相关概念视频
Animal Mitochondrial Genetics
7.6K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.6K
Mitochondrial Precursor Proteins
2.6K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
2.6K
Disorders of the Skeletal Muscle
955
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
955
Myasthenia Gravis: Diagnostic Tests
861
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
861
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K

